Use of Small Doses of Furosemide in Chronic Kidney Disease Patients with Residual Renal Function Undergoing Hemodialysis

Overview

Journal Clin Exp Nephrol

Publisher Springer

Specialty Nephrology

Date 2011 Mar 19

PMID 21416248

Citations 14

Authors

Helton P Lemes

Salustiano Araujo

Daniella Nascimento

Danny Cunha

Cesar Garcia

Vinicius Queiroz

Sebastiao R Ferreira-Filho

Affiliations

Soon will be listed here.

Abstract

Background: The objective of the present study was to verify whether chronic renal patients on hemodialysis (HD) with residual diuresis who were using small doses of furosemide present different levels of urinary volume and sodium excretion compared to patients with residual diuresis who do not use this drug.

Methods: We studied 19 chronic renal patients on HD who presented any level of residual diuresis. Urine was collected during the 24-h interdialytic period, and physical examinations and blood sampling took place immediately before the start of HD. Patients were divided into two groups: the diuretic group (DG, n = 10), in which patients had been using 40 mg of furosemide for at least 3 months, and the non-diuretic group (NDG, n = 9), in which patients used no diuretics.

Results: Although both groups presented the same average glomerular filtration rate (p > 0.05) and time in dialysis (p > 0.05) the DG presented an average of twice the urinary volume in 24 h (1142 ± 184 vs. 453 ± 135 ml/24 h, respectively; p = 0.008) and double the total excreted sodium mass compared to patients in the NDG (112 ± 22.4 vs. 45.2 ± 16.0 mEq/24 h, respectively; p = 0.02).

Conclusion: The results of this study have shown that chronic use of small doses of furosemide in chronic renal patients with residual diuresis could increase urinary volume and sodium excretion compared to patients who did not use this drug.

Citing Articles

Diuretics and mortality reduction in incident dialysis patients: a two-year observational study.

Ingwiller M, Bozman D, Florens N, Cerasuolo D, Vigneau C, Couchoud C Sci Rep. 2024; 14(1):27447.

PMID: 39523415 PMC: 11551180. DOI: 10.1038/s41598-024-65643-8.

Diuretic prescriptions in the first year of haemodialysis: international practice patterns and associations with outcomes.

Tabibzadeh N, Wang D, Karaboyas A, Schaeffner E, Jacobson S, Vega A Clin Kidney J. 2024; 17(7):sfae141.

PMID: 38989279 PMC: 11233991. DOI: 10.1093/ckj/sfae141.

Pharmacological management of hypertension and outcome among patients on hemodialysis at Muhimbili National Hospital, Tanzania: a cross-sectional study.

Mhagama D, Kilonzi M, Kunambi P, Buma D, Kalokola F, Ruggajo P Pan Afr Med J. 2024; 46:67.

PMID: 38282776 PMC: 10822098. DOI: 10.11604/pamj.2023.46.67.39778.

Benefits of Preserving Residual Urine Output in Patients Undergoing Maintenance Haemodialysis.

Dopierala M, Schwermer K, Hoppe K, Kupczyk M, Pawlaczyk K Int J Nephrol Renovasc Dis. 2023; 16:231-240.

PMID: 37868106 PMC: 10590073. DOI: 10.2147/IJNRD.S421533.

Association between hepatic oxygenation on near-infrared spectroscopy and clinical factors in patients undergoing hemodialysis.

Ueda Y, Ookawara S, Ito K, Sasabuchi Y, Hayasaka H, Kofuji M PLoS One. 2021; 16(10):e0259064.

PMID: 34673824 PMC: 8530328. DOI: 10.1371/journal.pone.0259064.

References

Ginsberg J, Chang B, Matarese R, GARELLA S . Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med. 1983; 309(25):1543-6. DOI: 10.1056/NEJM198312223092503. View

Medcalf J, Harris K, Walls J . Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int. 2001; 59(3):1128-33. DOI: 10.1046/j.1523-1755.2001.0590031128.x. View

Van Stone J . The effect of dialyzer membrane and etiology of kidney disease on the preservation of residual renal function in chronic hemodialysis patients. ASAIO J. 1995; 41(3):M713-6. DOI: 10.1097/00002480-199507000-00105. View

Chandna S, Farrington K . Residual renal function: considerations on its importance and preservation in dialysis patients. Semin Dial. 2004; 17(3):196-201. DOI: 10.1111/j.0894-0959.2004.17306.x. View

Vasavada N, Saha C, Agarwal R . A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease. Kidney Int. 2003; 64(2):632-40. DOI: 10.1046/j.1523-1755.2003.00124.x. View

van Olden R, van Meyel J, Gerlag P . Acute and long-term effects of therapy with high-dose furosemide in chronic hemodialysis patients. Am J Nephrol. 1992; 12(5):351-6. DOI: 10.1159/000168471. View

Lysaght M, Vonesh E, Gotch F, Ibels L, Keen M, Lindholm B . The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans. 1991; 37(4):598-604. View

Boesken W, Kult J . High-dose torasemide, given once daily intravenously for one week, in patients with advanced chronic renal failure. Clin Nephrol. 1997; 48(1):22-8. View

Sanjay S, Annigeri R, Seshadri R, Subba Rao B, Prakash K, Mani M . The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease. Nephrology (Carlton). 2008; 13(3):247-50. DOI: 10.1111/j.1440-1797.2007.00889.x. View

10.

Krediet R, Douma C, van Olden R, Ho-Dac-Pannekeet M, Struijk D . Augmenting solute clearance in peritoneal dialysis. Kidney Int. 1998; 54(6):2218-25. DOI: 10.1046/j.1523-1755.1998.00181.x. View

11.

. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(2 Suppl 1):S1-266. View

12.

Bragg-Gresham J, Fissell R, Mason N, Bailie G, Gillespie B, Wizemann V . Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS). Am J Kidney Dis. 2007; 49(3):426-31. DOI: 10.1053/j.ajkd.2006.12.012. View

13.

Rottembourg J, Issad B, Gallego J, Degoulet P, Aime F, Gueffaf B . Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc. 1983; 19:397-403. View

14.

Brater D, Anderson S . Response to furosemide in chronic renal insufficiency: rationale for limited doses. Clin Pharmacol Ther. 1986; 40(2):134-9. DOI: 10.1038/clpt.1986.151. View

15.

Moist L, Port F, Orzol S, Young E, Ostbye T, Wolfe R . Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000; 11(3):556-564. DOI: 10.1681/ASN.V113556. View

16.

Schmidt P, Loew D, Dycka J, Kopsa H, Balcke P, Zazgornik J . Comparison of the effects of muzolimine and furosemide in patients with end-stage renal failure on chronic dialysis. Eur J Clin Pharmacol. 1981; 20(1):23-6. DOI: 10.1007/BF00554662. View

17.

van Olden R, van Meyel J, Gerlag P . Sensitivity of residual nephrons to high dose furosemide described by diuretic efficiency. Eur J Clin Pharmacol. 1995; 47(6):483-8. DOI: 10.1007/BF00193698. View

18.

Smeby L, Wideroe T, Balstad T, Jorstad S . Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers. Blood Purif. 1986; 4(1-3):93-101. DOI: 10.1159/000169432. View

19.

Russo D, Memoli B, Andreucci V . The place of loop diuretics in the treatment of acute and chronic renal failure. Clin Nephrol. 1992; 38 Suppl 1:S69-73. View

20.

Hakim R . Clinical implications of biocompatibility in blood purification membranes. Nephrol Dial Transplant. 2000; 15 Suppl 2:16-20. DOI: 10.1093/ndt/15.suppl_1.16. View